Rennie, Christina http://orcid.org/0000-0001-9895-4758
Lotery, Andrew http://orcid.org/0000-0001-5541-4305
Payne, Jo
Singh, Moushmi
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Funding for this research was provided by:
Abbvie UK
AbbVie UK
Abbvie Ltd
Article History
Received: 25 November 2022
Revised: 27 June 2023
Accepted: 14 July 2023
First Online: 4 August 2023
Competing interests
: CR has been a Consultant for Allergan (A subsidiary of AbbVie Ltd), Bayer, Novartis, Roche, and Alimera. She has also received an educational grant from Bayer and sponsored research with Allergan (A subsidiary of Abbvie Ltd). AJL is a consultant for Abbvie, Appelis, Novartis, Roche, Gyroscope Therapeutics, Biogen and Eyebio. He has equity in Gyroscope Therapeutics and Eyebio. JP is an employee of AbbVie and may hold stocks and shares. MS was a contracted employee of AbbVie at the time of this work and does not hold stocks and shares. FG has been a consultant for Allergan (A subsidiary of AbbVie), Apellis, Boehringer Ingleheim, Novartis and Roche. He lectures for Allergan (A subsidiary of AbbVie), Bayer, Heidleberg, Novartis and Roche. He has also received educational grants from Allergan (A subsidiary of AbbVie), Novartis and Roche.